Carcinoembryonic antigen (CEA) is synthesized during development in the fetal gut, and is re-expressed in increased amounts in intestinal carcinomas and several other tumors. Anti-CEA is reportedly useful in identifying the origin of various metastatic adenocarcinomas and in distinguishing pulmonary adenocarcinomas (60-70% are CEA+) from pleural mesotheliomas (rarely or weakly CEA+).
Applications:
Suitable for use in ELISA. Other applications not tested.
Recommended Dilutions:
Optimal dilutions to be determined by the researcher.
Recommended Pair:
Suitable for use as the capture or solid phase antibody. Matched to C1299-87E, C1299-87F or C1299-87U as the detection or conjugate (label) antibody.
Also suitable for use as the detection or conjugate (label) antibody. Matched to C1299-87F as the capture or solid phase antibody.
Source:
Ascites
Affinity Constant:
1x10e9L/mole
Storage and Stability:
May be stored at 4 degrees C for short-term only. Aliquot to avoid repeated freezing and thawing. Store at -20 degrees C. Aliquots are stable for 12 months. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.